Skip to content

Agilon Health AGL EPS (Diluted)

EPS (Diluted) at other companies

CVS Health logo
CVS HealthCVS
$2.30+63.1%
Astrana Health logo
Astrana HealthASTH
$0.29+107%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$0.02-33.3%
Alignment Healthcare logo
Alignment HealthcareALHC
$0.05+200%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$0.05
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0.19+375%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's EPS (diluted)?
Agilon Health (AGL) reported EPS (diluted) of $2.94 in Q1 2026.
How has Agilon Health's EPS (diluted) changed year-over-year?
Agilon Health's EPS (diluted) increased by 302.7% year-over-year, from $0.73 to $2.94.
What is the long-term trend for Agilon Health's EPS (diluted)?
Over 4 years (2021 to 2025), Agilon Health's EPS (diluted) has grown at a -29.8% compound annual growth rate (CAGR), from -$1.03 to -$0.25.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.